Harta Djaya Karya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Harta Djaya Karya Tbk. trades at Rp112 (market cap 297.32B, 17.9M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Harta Djaya Karya Tbk. is the larger of the two by market cap, and Harta Djaya Karya Tbk. is more actively traded (17.9M versus 324K). Which is the better fit depends on your goals.
| MEJA | OBAT | |
|---|---|---|
Market Cap | 297.32B | 166.01B |
Volume | 17.9M | 324K |
Lot | 179.04K | 3.24K |
Turnover | 1.99B | 77.68M |
Average Price | 111.27 | 239.75 |
Value | 1.99B | 77.68M |
Indicative Equilibrium Price | 112 | 240 |
Indicative Equilibrium Volume | 898 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Harta Djaya Karya Tbk (the Entity) was established based on the Notarial Deed of Musa Muamarta., S.H., No. 27, dated November 22, 2012. The entity began commercial operations in 2012.
Read more on MEJA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →